Home > Healthcare > Medical Devices > Therapeutic Devices > Dialysis Market
As per type, the dialysis market share from the hemodialysis segment is estimated to reach over USD 135 billion by 2032 attributed to the rising number of end-stage renal disease patients worldwide. In 2021, around 786,000 people suffer from ESRD in the U.S., as per the National Institute of Diabetes and Digestive and Kidney Diseases. Moreover, hospitals are focusing on improving the availability of hemodialysis to complement their current renal services, which is expected to promote segment expansion. For instance, in July 2022, Pantai Hospital Klang opened a new Haemodialysis Centre to serve chronic kidney disease patients in Klang, Malaysia, and the surrounding area, allowing them to receive treatment closer to home.
Services segment held over 78% share of the dialysis market in 2022 and is likely to grow exponentially through 2032 with the surging occurrences of renal illnesses, which is increasing the number of patients needing dialysis and transplants. Industry participants are seizing opportunities to offer new dialysis delivery services and other technologies to treat the most advanced stages of kidney function failures and disease. For instance, in March 2022, SEHA Kidney Care, a subsidiary of Abu Dhabi Health Services Company (SEHA) which is UAE's largest healthcare network, launched an overnight dialysis service to meet the community's diverse needs. Such initiatives are anticipated to stimulate segment growth.
In terms of end-use, the dialysis market by the home dialysis segment generated over USD 28 billion in 2022, owing to the COVID-19 pandemic, which has increased the preference for home dialysis. Home dialysis procedure provides greater patient autonomy, financial benefits, and treatment-related flexibility, and is associated with improved quality of life and survival. Furthermore, to alleviate the strain on dialysis facilities and provide a more sustainable dialysis care delivery system, governments, and healthcare institutions in densely populated underdeveloped regions are promoting home-based dialysis, which is likely to augment segment revenues.
North America dialysis market valuation is anticipated to exceed USD 65.5 billion by 2032 owing to the increasing prevalence of chronic kidney disease & end-stage renal disease. As per the National Institute of Diabetes and Digestive and Kidney Diseases, more than one in every seven adults in the U.S. suffers from chronic kidney disease. Furthermore, the increasing availability of reimbursement schemes and favorable government initiatives are projected to favor the U.S. dialysis market, thereby bolstering regional business expansion. To cite an instance, the Centers for Medicare & Medicaid Services (CMS) reimburses dialysis expenses through a prospective payment system (PPS), which allows for the payment of a predetermined amount to dialysis service providers.